Cao et al. [89] provided compelling evidence that DNA methyltransferase inhibition using 5-aza-2′-deoxycytidine (decitabine) improved survival in CLP-induced severe sepsis by attenuating NF-κB pathway activation and reducing pro-inflammatory cytokine release. Here, NFKB1 is linked to Sepsis.